CVS vs SYM · P/E 16, rev $402.07B vs rev $2.25B
CVS Health Corp (CVS) versus Symbotic Inc (SYM) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. SYM currently screens at market cap $24.25B.
Not investment advice. Open the CVS and SYM stock pages for the full models.
Not investment advice.